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The body iron homeostasis is a not fully understood complex process. Despite the fact that some components of this process have
been described in the literature, the complete model of the whole process has not been proposed. In this paper a Petri net based model
of the body iron homeostasis is presented. Recently, Petri nets have been used for describing and analyzing various biological processes
since they allow modeling the system under consideration very precisely. The main result presented in the paper is twofold, i.e., an infor-
mal description of the main part of the whole iron homeostasis process is described, and then it is also formulated in the formal language
of Petri net theory. This model allows for a possible simulation of the process, since Petri net theory provides a lot of established analysis
techniques.
 2006 Elsevier Inc. All rights reserved.
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Iron is a key component of many reactions in the body
and is required for a variety of normal cellular functions
and vital for proper growth and development. However,
natural iron is quite insoluble and excess of iron is harmful,
since it can catalyze the formation of potentially damaging
toxic oxygen radicals. Humans also have very limited
capacity to excrete iron. Therefore, cells have developed
mechanisms to improve solubility of iron to control intra-
cellular iron concentrations at the point of iron absorption
in the small intestine and other tissues. The intestinal iron
absorption is modulated in response to the level of iron1532-0464/$ - see front matter  2006 Elsevier Inc. All rights reserved.
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2 Fax: +48 61 8771525.stored by the body and by the amount of iron needed for
erythropoiesis. This regulation is thought to operate
through two regulators, namely, the store regulator and
the erythroid regulator. When the concentration of iron
in the stores decreases, the store regulator increases the
iron uptake until the reserves are replete. When the iron
stores are increased, it reduces the intestinal iron absorp-
tion, thus preventing iron overloading. Both the stores reg-
ulator and the erythroid regulator are believed to be
components of the plasma being able to communicate
between the sites of iron utilization and mobilization,
respectively, and the intestinal cells. So far, the signaling
pathway and molecular components involved in the regula-
tion of iron absorption through these two regulators have
remained elusive. Despite many components of this com-
plex process have been described in the literature, to the
best of our knowledge the complete model of the whole
process has not been proposed. It should be also noted that
these descriptions are usually informal and hence not very
precise (they are not expressed in the language of Petri net
or other mathematical theory). Formulation of a complete
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Fig. 1. An example of a simple Petri net.
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cess in a language precise enough for a possible analysis
and simulation of the process is the main goal of the paper.
For this purpose a mathematical structure called Petri net
has been chosen. It is a structure for modeling complex sys-
tems proposed in the early 1960s by Carl A. Petri [1]. Until
recently the most popular area of applications of Petri nets
were technical systems. The situation has changed in the
last decade with a rapid growth of computational biology.
Since then Petri nets are being used for describing and ana-
lyzing various biological processes, e.g., metabolic path-
ways, signal transduction pathways, and gene-regulatory
networks (cf. [2–4]). The reason for choosing Petri nets as
a language for modeling the iron homeostasis is their abil-
ity to model the system under consideration very precisely.
Thus, the developed Petri net model is introduced in this
paper to illustrate the biological processes described below.
An interested reader is invited to concern with a speciﬁca-
tion of the model development, the detailed analysis of the
Petri net and a validation of the model in [5]. Moreover, in
[6] some biological results obtained on the basis of our
Petri net can be found. These results are veriﬁcations of
some hypotheses and answers to some open questions con-
cerning the human body iron homeostasis.
The organization of the paper is as follows. In Section 2
a brief introduction to Petri nets will be given. It should be
helpful for non-specialists in understanding the presented
model. In Section 3 the iron homeostasis process will be
described in a less formal way ﬁrst and then the model
based on Petri nets will be presented. The paper ends with
Conclusions where some remarks on the possible applica-
tions of the presented model are given.
2. Materials and methods
As it has been explained in the previous section, the
model of the body iron homeostasis presented in this paper
is based on Petri net theory. This approach in qualitative
modeling of biochemical networks comprises simulation
visualization tools [7] as well as several analysis techniques
[8]. In the following, we give a short overview of Petri nets.
More formal deﬁnitions are given e.g., in [9–11].
Petri nets are bipartite graphs (for an introduction to
graph theory see [12]). That means there are two kinds of
nodes in the net, called places and transitions, and arcs
connect only two nodes of diﬀerent types. While the places
typically stand for the passive system elements as biochem-
ical components (e.g., Fe2+ or apotransferrin (ApoTf)),
which may be interpreted as conditions, the transitions rep-
resent the active system elements as events or biochemical
reactions (e.g., Fe2+ oxidation by hephaestin (Heph) or
binding of ApoTf and Fe3+). Thus, every arc in the net
connects an active and a passive element and since there
are only directed arcs in Petri nets, they are represented
by arrows. In graphical representations, places are depicted
as circles and transitions as rectangles. According to the arc
direction, every place has a set of pretransitions and a set ofposttransitions. Since the presented net is transition-bor-
dered, these sets are non-empty. In turn, transitions with-
out preplaces (postplaces) are called input (output)
transitions and are depicted as ﬂat rectangles. The ﬁring
of input transitions is not restricted from the net, i.e., the
event modeled by an input transition may take place any
time. Contrary to that, a transition with preplaces repre-
sents an event, which is only enabled to take place when
all the preconditions of that event are fulﬁlled. The fulﬁll-
ment of a condition is realized via tokens residing in places.
If all preplaces of a transition are marked suﬃciently with
tokens (i.e., if the corresponding biochemical components
are available), this transition may ﬁre (i.e., the reaction
takes place). If a transition ﬁres, one token is removed from
each of its preplaces and added to each of its postplaces.
Thus, the tokens are the dynamic elements of the system.
Altogether, arcs connect an event with its preconditions
which must be fulﬁlled to trigger this event, and with its
postconditions which will be fulﬁlled when the event takes
place. Principally, a place in a discrete net may carry any
integer number of tokens, indicating diﬀerent degrees of
fulﬁllment. Since the number of preplaces of a transition
generally has not to be equal to the number of postplaces
of this transition, the number of tokens in the whole net
is not conserved. If a condition must be fulﬁlled, but the ﬁr-
ing of a connected transition does not remove any tokens
from it, these nodes are connected via two converse arcs.
In the following, these arcs are represented by bidirectional
arrows as a short-hand notation, and are called read arcs.
Fig. 1 depicts an example of a Petri net, which illustrates
the ﬁring process. With the ﬁring of input transition t1 one
token is put at place p1. This token enables the transitions
t2 and t3 to ﬁre, i.e., both of them are able to ﬁre but only
one of them can really ﬁre, if there is only one token at
their common preplace (i.e., p1). Since t2 is an output tran-
sition, it can only remove this token from p1. The ﬁring of
t3 would remove this token and put one token at each place
p2 and p3. A token from place p3 is removed by ﬁring of its
posttransition t4.
The distribution of the tokens over all places describes a
certain system state and is called the marking of the net.
According to this, the initial marking of a net describes
the system state before any transitions have ﬁred.
To avoid immoderate arc crossings, the construct of log-
ical nodes is used in the graphical representation of the net.
A logical node is represented by its name and exists in
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Thus, a node deﬁned as a logical one is identically equal
to every other logical node with the same name and they
are identiﬁed as one node which occurs in several graphical
copies in the net. To distinguish these special nodes from
ordinary ones, they are tinted grey. The model is one con-
nected Petri net, but in the following it is presented and dis-
cussed in the form of three subnets which are connected via
logical nodes in the original model.
3. Results and discussion
In this section a description of the iron homeostasis is
given. It is followed by a description of the Petri net based
model of this process.
3.1. Informal description of the body iron homeostasis
The form in which iron is presented to the digestive tract
aﬀects the iron absorption, and inorganic iron ions change
their oxidation state during the absorption process. There
are two major forms of dietary iron: heme iron (ferrous,
Fe2+) and non-heme iron (ferric, Fe3+). Heme iron
(Hem(Fe2+)), found primarily in red meats, is the most eas-
ily absorbed form. Heme iron is ingested as myoglobin and
hemoglobin. In the presence of gastric acid, the globin mol-
ecule is split oﬀ and the ferrous iron is liberated and trans-
ported with its phosphorin ring from the stomach into the
duodenum and jejunum via a not yet characterized duode-
nal heme receptor [13,14]. Heme is oxygenated by Heme
oxygenase (HO) before it reaches the labile iron pool
(LIP) in the cell. Other forms of iron are bound to some
other organic constituent of the food. Cooking tends to
break these interactions and increase iron availability. Iron
ions undergo important changes of oxidation state during
digestion and absorption. The change occurs in the stom-
ach. Here, iron Fe3+ is reduced to Fe2+. This reduction is
favored by the low pH (in the range from 2 to 5). Reducing
agents, such as ascorbic acid, assist this process. Reduction
is important because the ferrous iron dissociates from
ligands more easily than the ferric one. Fe3+ when ingested
into a stomach unable to produce acid, forms insoluble
iron complexes, which are not available for absorption.
Then Fe2+ is transported into the mucous membrane of
the small intestine by divalent metal transporter-1, which
is also known as natural resistance-associated macrophage
protein-2 or divalent cation transporter-1 (DMT1/
Nramp2/DCT1) situated on the apical side of mucous
membrane. If the iron is orally supplemented (in the Fe2+
form) it is also directly transported by the transporter men-
tioned above. If the iron (in the Fe3+ form) is administrated
parenterally it needs to be reduced to ferrous ion by ferri-
reductase, called duodenal cytochrome b (Dcytb) situated
like DMT1/Nramp2/DCT1 at the luminal site of the small
intestine mucous membrane [15,16].
The prevailing view is that all forms of iron entering
cells reach a cytosolic pool of metabolically active or labileiron. The LIP is the compartment from which most of the
metal is either: metabolically drawn into Fe-dependent
enzymes, transported into mitochondria for heme synthesis
or incorporated into ferritin for secure storage and/or
detoxiﬁcation. LIP is comprised of forms of iron bound
to a variety of medium and low aﬃnity binding ligands.
Those might vary in composition and quantities in diﬀerent
physiological settings. Operationally, LIP can be regarded
as that component of cell iron that is accessible to a partic-
ular chelator or a class of chelators. Topologically, it is
identiﬁed primarily with the cytosol and as such, it is
regarded as the crossroad of the cellular iron traﬃc. Bio-
chemically, LIP has been deﬁned as the ‘regulatory’ or ‘reg-
ulated’ pool of cell iron, since depending on the cells
system, its level is apparently maintained within a constant
range [17]. The limits of the latter are such that, on the one
hand, they meet the cellular requirements for iron and, on
the other hand, they prevent excesses from developing and
triggering reactive oxygen species (ROS) formation. Most
cells regulate their LIP by iron responsive proteins (IRPs)
that sense its level, and in turn control the translation of
transferrin receptor (TfR) and ferritin in a compensatory
manner [18,19]. A rise in iron uptake increases the LIP
and results in IRPs inactivation. The latter concomitantly
evokes ferritin synthesis and blocks TfR synthesis by
inducing TfR mRNA degradation. The iron deprivation
causes opposite eﬀects. The IRP mode of action on ferritin
and TfR synthesis and erythroid heme synthesis is via spe-
ciﬁc mRNA–protein interactions. Two IRPs have been
invoked in those interactions, but only the activity of the
IRP1 is apparently directly aﬀected by the cytosolic iron
(i.e., LIP) concentrations and modulated by heme, cell
redox status, and other factors. Other regulatory modali-
ties found in some cells comprise the increase in LIP by
transcriptional activation of TfR expression and the with-
drawal of iron from the LIP via a transcriptional induction
of ferritin synthesis. So, some fraction of the iron taken up
from the LIP is deposited as ferritin within the enterocyte,
and the remainder is transferred by ferroportin (Fpn) at the
basolateral site of the small intestine mucous membrane to
the plasma-bound transferrin (Tf). When the enterocyte
defoliates, iron deposited as ferritin is lost into the intesti-
nal lumen. This mechanism of iron loss is probably over-
whelmed by the large amounts of iron ingested. The
amount of iron entering the body depends largely on two
factors: total body iron concentration and the rate of
erythropoiesis.
So, Fe3+ transported by Fpn must be reduced by a ceru-
loplasmin (Cp) homologue–Heph [20], mostly expressed
through the small intestine and colon, to be prepared for
the Tf transport. Normally, all of non-heme iron in the cir-
culation is bound to holotransferrin (HoloTf). Only about
30% of Tf binding sites are occupied, so that most of the
protein, which is called apotransferrin is free of iron and
is able to bind one or two Fe3+ ions in transferrins’
N- and/or T-terminal ends (Nt(Fe3+)HoloTf or HoloTf
(Fe3+)Ct or HoloTf(Fe3+)2). The ferrous ion in connection
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serum iron is carried by HoloTf, and is taken up by cells
as an iron bound HoloTf. On the cell surface iron bound
HoloTf binds to transferrin receptor 1 (TfR1) and as the
HoloTf(Fe3+)–TfR1 complex is internalized by receptor
mediated endocytosis (RME) through clathrin coated pits
into endosomes. HoloTf binds to the TfR in 2:2 (Tf: TfR
subunit) stoichiometry [21,22]. After internalization of this
complex, iron Fe3+ is released from HoloTf under the
endosomal acidic conditions (pH varies with the cell type,
ranging from 5.5 to 6.0 [23]) and occurs in the reduced
form as Fe2+. HoloTf after Fe2+ releasing is called ApoTf.
Next, ApoTf and TfR1 complex (ApoTf–TfR1) is exocyto-
sed. After the return of the complex to the cell surface, the
extracellular pH triggers the release of ApoTf, allowing
another round of binding and RME to begin. Then the
ferrous ion is transported by DMT1/Nramp2/DCT1 trans-
porter to the cytosol or mitochondria of the all-prolifera-
tive cells and reaches the LIP [24]. The expression of
these transport genes is strongly related to the body iron
homeostasis, since the small intestine expression of
DMT1, Dcytb, Fpn and to a lesser extent of Heph is
increased in the iron deﬁciency anemia [25,26].
Expression of TfR1 on cells surface is also regulated at
the transcriptional level by the status of cellular prolifera-
tion and oxygen saturation. Another well-characterized
mechanism of TfR1 expression regulation is performed at
the posttranscriptional level. When the iron concentration
is insuﬃcient, the iron regulatory proteins (IRPs) bind to
iron responsive elements (IREs) of TfR1 mRNA resulting
in stabilization of the transcript. In excess of the iron con-
centration, IRPs are released from IREs and the transcript
is degraded. The recently discovered Tf receptor, called
transferrin receptor 2 (TfR2), is similar to TfR1 [27,28].
However, if the main function of TfR2 is to transport iron
into the cells, the iron overload would be expected to sup-
press the expression of TfR2 to keep cellular iron homeo-
stasis. This paradoxical expression proﬁle of TfR2 may
be suggesting that it has another function besides the cellu-
lar iron uptake. Alternatively, TfR2 may simply be another
receptor for Tf, and cells may be controlling the iron inﬂux
by using two diﬀerent receptors for Tf; one is the high aﬃn-
ity receptor TfR1, whose expression is regulated by the cel-
lular iron status, and the other is the low aﬃnity receptor
TfR2, whose expression depends on the cell cycle rather
than the iron status, because its transcript lacks an IRE
[29].
It is well known that on the erythroid precursors cells
surface is the vest TfR1 concentration. Erythroid precur-
sors need an extraordinary amount of iron to support the
hemoglobin synthesis and diﬀerentiation into mature red
cells. The density of TfR on the cell surface is changing
during the erythroid maturation. A strict correlation exists
between the iron requirement and the transferrin receptors
number, indicating that the abundance of transferrin recep-
tors on the cell surface is a major determinant of the ery-
throid iron uptake [30]. Because maturing red cells shedtheir transferrin receptors, the quantity of the soluble
transferrin receptor in plasma reasonably reﬂects erythro-
poiesis. It is known, that the mature red cells synthesis is
stimulated by erythropoietin (EPO), a hormone produced
by the kidney. In the case of a low serum iron concentra-
tion, the EPO synthesis is increased to enhance the erythro-
cytes production.
The red blood cells live in the human body about 120
days and after this period of time one-nuclear cells phago-
cytose them. These cells play a key role in the iron metab-
olism, as they are responsible for the recirculation of iron
derived from eﬀete red blood cells, so that it may enter
the circulation, bind to Tf, and be transported to the bone
marrow for red cell production [31]. Before that, heme iron
from red blood cells must ﬁrst be released from hemoglobin
by HO and transported by natural resistance-associated
macrophage protein-1 (Nramp-1) from a phagolysosome
to the one-nuclear cell cytoplasm. Another way of iron
delivery to one-nuclear cells cytoplasm is the iron transport
via HoloTf(Fe3+)–TfR1 complex which is able to take up
signiﬁcant amounts of iron from HoloTf. This process pro-
ceeds like the RME route. Next, Fe2+ reaches LIP, the
compartment from which it is metabolically drawn into
enzymes, transported into mitochondria for the heme syn-
thesis or incorporated into ferritin for secure storage and/
or detoxiﬁcation, as shown above. Furthermore, changes
in the iron metabolism during immune and inﬂammatory
responses which result in reduced serum iron (hypoferre-
mia) and anemia are thought to be due, at least in a part,
to changes in iron handling by one-nuclear cells. What is
going on with LIP depends on the body iron status. If there
is a low concentration of iron, iron (Fe2+) from one-nucle-
ar’s LIP is mostly transported out by Fpn. Ferroportin,
situated in the small intestine membrane and in the one-nu-
clear cells is strongly regulated by hepcidin, a liver
expressed antimicrobial peptide, which is upregulated by
bacterial lipopolysaccharide. Then, iron is oxidized to fer-
ric ion by ceruloplasmin (Cp), a plasma metaloprotein syn-
thesized and secreted by the liver, and in this form is able to
connect with ApoTf and to be transported to the cells with
TfR on its surfaces. Ceruloplasmin may play an essential
role in determining the rate of iron eﬄux from cells with
mobilizable iron stores. On the other hand, in case of an
abnormal higher body iron concentration, iron from the
LIP is mostly transferred to the body iron store (ferritin),
where iron is oxidized and which synthesis is regulated by
iron requirements via IRP system. The mobilization of
the iron from the ferritin is much more poorly understood
than the deposition in the storage protein [32].
During the inﬂammatory process the body iron metabo-
lism is changing, among others iron is not released from
body iron stores (ferritin), to enable the development of
microorganisms which need iron for their growth. Infec-
tious and inﬂammatory disease commonly results hypofer-
remia which if prolonged can lead to anemia (the anemia of
chronic disease, ACD). It is generally thought that inﬂam-
mation alters macrophage iron homeostasis, resulting in an
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giving rise to the hypoferremia and anemia, although in
the latter event defects in erythropoiesis may also be
involved [33]. One might speculate that the iron sequestra-
tion is of beneﬁt during the early acute stages of infectious
disease in order to reduce the iron availability to microor-
ganisms, but that the subsequent development of an adap-
tive immune response requires iron to be ‘unlocked’ in
order to allow a proper immune function. A protein whose
production is modulated in response to inﬂammation
(positive correlation), anemia and hypoxia (negative corre-
lation) is hepcidin. An elevated expression of HAMP (hep-
cidin antimicrobial peptide) gene, which is responsible for
the high hepcidin production during inﬂammatory process,
is mediated among others by the higher interleukin-6 (IL-6)
serum concentration [34]. This situation results in two phe-
nomena: a reduced iron intestinal absorption, and in an
iron increase in the one-nuclear cells [35,36]. The ﬁrst phe-
nomenon follows from the fact that the iron uptake by
duodenal enterocyte appears to be largely regulated by
hepcidin. In rats, changes in hepcidin expression have
shown a close temporal relationship with changes in the
duodenal iron transporter expression, like (DMT1/
Nramp2/DCT1) and Dcytb [37,38]. Recently, it has been
found that hepcidin regulates the cellular iron eﬄux byHem(Fe2+)uptake
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and degradation [39,40]. In the latter phenomenon inﬂam-
matory-induced hepcidin expression, causing Fpn degrada-
tion might account for the iron sequestration within the
one-nuclear cells in the reticuloendothelial system (RES).
Moreover, the expression of hepcidin appears to be sensi-
tive to the activity of the erythroid bone marrow. In a
recently suggested model for the regulation of hepatic hep-
cidin expression [40], hepatocyte surface HFE (the hemo-
chromatosis protein) competes with HoloTf(Fe3+) for the
binding on surface TfR1 which is TfR2 competitor. The
unbound surface HFE and a higher concentration of
HoloTf(Fe3+)–TfR2 complex were proposed to increase
the hepatic hepcidin expression and its release. According
to the model, the iron deﬁciency would lead to a decrease
of circulating HoloTf(Fe3+), and the number of free sur-
face TfR1s would increase, resulting in a decreasing frac-
tion of free surface HFE, and a lower concentration of
HoloTf(Fe3+)–TfR2 complex.
3.2. Petri net based model
As mentioned above, we have developed a Petri net
which models the main part of the whole processes of the
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validation is described in discussed [5]. The model is a
graph, which is presented in the following as three subnets,
shown in Figs. 2–4, respectively. These subnets are con-
nected with each other via some logical nodes. Fig. 5 shows
in which ways these logical places connect the three subnets
with each other. An overview of the whole model is given in
Fig. 6.
Considering the presented model, there are several
tokens residing in places in the initial marking of the
net. These tokens indicate the presence of some compo-
nents previous to any iron uptake and they give the ini-
tial marking representing that system state which is
assumed to be the body state on normal physiological
conditions.Fe3+_in _serum
binding_ApoTf+Fe3+ApoTf
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Fig. 3. The part of the Petri net modeling iron pathway3.2.1. Subnet 1—iron uptake and transport through the small
intestine
The part of the Petri net modeling the iron uptake and
the iron transport through the small intestine is shown in
Fig. 2. In the digestive tract, there are diﬀerent ways of iron
absorption. Therefore, the model includes four input tran-
sitions representing diﬀerent forms of iron: heme iron
through the transition Hem(Fe2+)uptake and non-heme
iron through the transitions (Fe2+)uptake, (Fe3+)uptake,
and (Fe3+)uptake_parenteral, respectively. Not depending
on the fact which of the input transitions puts tokens in
the net, all these tokens arrive at the place
LIP(in_small_intestine) after passing several places, accord-
ing to the special iron form during the uptake and the cor-
responding processing and transport of the iron ions.ApoTf TfR1
TfR1
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Fig. 4. The part of the Petri net corresponding to some auxiliary conditions necessary for the model.
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guished, represented by the places Fe_serum_high,
Fe_serum_medium, and Fe_serum_low, respectively. Inde-
pendent of the ﬁring of any transitions, there is exactly
one token, which only circulates between those three plac-
es, indicating the actual iron level. In the initial marking,
this token is placed at the medium iron level, which stands
for a normal state. Depending on that level, the LIP in the
small intestine is spitted to its use. In the case of a high iron
level (which is measured by inactive IRP), the iron from
LIP is on the one hand transported into mitochondria
for Fe-dependent enzymes. On the other hand, the iron is
incorporated into ferritin for storage. If the iron level
decreases to a low level and if there is no inﬂammation in
the system (modeled in subnet 3), the iron from this store
is released and is then freely available in the small intestine.
In the case of a low iron level (measured by active IRP), the
iron from LIP is also transported to mitochondria and is
directly available in a free form. In the case of a medium
iron level, the LIP is split to all these three usages.
To transport the available iron out of the small intestine,
Fpn is needed. Subnet 3 shows how the Fpn level is aﬀected
by the level of hepcidin. If there is enough Fpn available,
the transition transport_out_of_small_intestine is enabled
to ﬁre, removes a token from place available_Fe2+ and
puts a token to place Fe2+_in_serum. A token at this place
is removed by ﬁring of transition oxidation(Heph), whichputs a token to place Fe3+_in_serum. Tokens at this place
can lead to an increase of the iron level or they are alterna-
tively used in subnet 2, where this place occurs as an input
place.
3.2.2. Subnet 2—iron pathway through the erythrocyte cell
and the one-nuclear cell
In Fig. 3 there is shown the part of the net modeling iron
pathway through the erythrocyte cell and the one-nuclear
cell, respectively. The input place Fe3+_in_serum of this
subnet gets tokens from subnet 1. If there is an additional
token at place ApoTf (what is aﬀected by the presence of
cytokine IL-6 in subnet 3), transition binding_ApoTf+Fe3+
may ﬁre, and it removes those tokens and puts one at place
HoloTf(Fe3+). If TfR1 is present, the HoloTf(Fe3+)–TfR1
complex is internalized by the receptor mediated endocyto-
sis either into pre-erythrocyte cells or into one-nuclear cells
(shown in the net in form of the middle and the right path-
way, respectively). However, the amount of available TfR1
depends on the iron level (shown in subnet 3) and if this
amount decreases, there is relatively more TfR2, which
then triggers the transition HoloTf (Fe3+)+TfR2. Thereby,
place free_HFE gets a token, which inﬂuences the hepcidin
level in subnet 3.
Both in pre-erythrocytes and in one-nuclear cells iron is
released from the HoloTf(Fe3+)–TfR1 complex by low
pH. Thereafter, the remaining complex is exocytosed and
Fig. 5. The general structure of the model—the connections between the three subnets via logical places. The arrows show in which way each place is
connected with transitions in the corresponding subnet.
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LIP. Under a low level of iron in serum and enough avail-
able Fpn, the iron is transported out of the cell. Contrary
to that, the iron in the pre-erythrocyte cell is needed to sup-
port hemoglobin synthesis and diﬀerentiation into mature
red cells. The transition erythrocyte_synthesis depends also
on tokens at the places erythrocyte_synth_support and
much_EPO which are contained in subnet 3. Since there
is no possibility to include any information concerning time
in an ordinary, discrete Petri net, the place erythrocyte has
the posttransition phagocytosis_in_one_nuclear_cell
(although only the about 120 days old erythrocyte cells
are phagocytosed). Via that way the iron in the erythrocyte
cell is also admitted to LIP in the one-nuclear cell. There-
fore, the place LIP is identiﬁed with the above mentioned
place LIP (i.e., a logical place is used here). If the iron level
in serum is high, the iron from LIP is incorporated into fer-
ritin for storage. By analogy with the above mentioned
processes in the small intestine, the iron is released out of
storage if the amount of iron in serum is decreasing to alow level and if there is no inﬂammation in the system
(see place no_inﬂammation in subnet 3). The iron which is
released out of the one-nuclear cell is represented by a
token at the logical place Fe3+_in_serum. This place also
serves as input place for this subnet.
3.2.3. Subnet 3—auxiliary conditions
The third part of the Petri net is shown in Fig. 4. This
subnet is composed of ﬁve subnets, which stand for some
auxiliary conditions of the model, mainly some regulations.
The left depicted nets concern the RNA based regulation of
TfR1 via IRP depending on the iron level and the support
of erythroid maturation which depends on the iron level in
the serum and the regulation of the EPO concentration.
The nets below represent the natural iron consumption in
the serum and the regulation of Fpn via some signals.
These signals result from the ﬁring of the transitions hepci-
din_increase(expressed_in_liver) (negative Fpn signal) and
hepcidin_inhibition (positive Fpn signal), respectively (see
the net on the right-hand side). The last mentioned net
Fig. 6. The whole Petri net model. Functional units are marked with rectangles and locally bounded units with ellipses, each inscribed.
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regulation of ApoTf and hepcidin.
4. Conclusions
In the paper, the main part of the whole process of iron
homeostasis has been presented. The process has been
described in the language of Petri net theory, which makes
the description very precise on one hand, and on the other
hand, it allows for a possible simulation of the process.
Furthermore, Petri net theory provides a lot of established
analysis techniques. Such a net analysis, being a goal of our
future research, should make possible a more detailedinvestigation of the process. In general, it may lead to a for-
mulation of some hypotheses, which can be then veriﬁed in
the laboratory or clinical research (cf. [6]).References
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